000 01194 a2200325 4500
005 20250511183608.0
264 0 _c19921208
008 199212s 0 0 eng d
022 _a0706-7437
024 7 _a10.1177/070674379203700704
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCollins, E J
245 0 0 _aClozapine in the treatment of refractory schizophrenia: Canadian policies and clinical guidelines.
_h[electronic resource]
260 _bCanadian journal of psychiatry. Revue canadienne de psychiatrie
_cSep 1992
300 _a482-96 p.
_bdigital
500 _aPublication Type: Guideline; Journal Article; Practice Guideline
650 0 4 _aClozapine
_xadverse effects
650 0 4 _aDrug Monitoring
650 0 4 _aDrug Prescriptions
650 0 4 _aHumans
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aLalonde, P
700 1 _aJones, B D
700 1 _aAddington, D
700 1 _aMacCrimmon, D J
700 1 _aMacEwan, G W
700 1 _aTeehan, M D
773 0 _tCanadian journal of psychiatry. Revue canadienne de psychiatrie
_gvol. 37
_gno. 7
_gp. 482-96
856 4 0 _uhttps://doi.org/10.1177/070674379203700704
_zAvailable from publisher's website
999 _c1429636
_d1429636